These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22169630)

  • 61. Global Acoustic Speech Temporal Characteristics for Mandarin Speakers With Parkinson's Disease During Syllable Repetition and Passage Reading.
    He D; Feenaughty L; Wan Q
    Am J Speech Lang Pathol; 2023 Sep; 32(5):2232-2244. PubMed ID: 37625136
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The cortical signature of symptom laterality in Parkinson's disease.
    Heinrichs-Graham E; Santamaria PM; Gendelman HE; Wilson TW
    Neuroimage Clin; 2017; 14():433-440. PubMed ID: 28271041
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lateralized cognitive functions in Parkinson's patients: A behavioral approach for the early detection of sustained attention deficits.
    Agosta S; Magnago D; Galante E; Ferraro F; Magherini A; Di Giacopo R; Miceli G; Battelli L
    Brain Res; 2020 Jan; 1726():146486. PubMed ID: 31580872
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Frequency of speech disruptions in Parkinson's Disease and developmental stuttering: A comparison among speech tasks.
    Juste FS; Sassi FC; Costa JB; de Andrade CRF
    PLoS One; 2018; 13(6):e0199054. PubMed ID: 29912919
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Residual signal auto-correlation to evaluate speech in Parkinson's disease patients.
    Pereira JC; Schelp AO; Montagnoli AN; Gatto AR; Spadotto AA; de Carvalho LR
    Arq Neuropsiquiatr; 2006 Dec; 64(4):912-5. PubMed ID: 17220994
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stop consonant production in isolated and repeated syllables in Parkinson's disease.
    Connor NP; Ludlow CL; Schulz GM
    Neuropsychologia; 1989; 27(6):829-38. PubMed ID: 2755591
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence of developmental speech dysfluencies in individuals with Parkinson's disease.
    Hartelius L
    Folia Phoniatr Logop; 2014; 66(3):132-7. PubMed ID: 25413693
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Smartphone Allows Capture of Speech Abnormalities Associated With High Risk of Developing Parkinson's Disease.
    Rusz J; Hlavnicka J; Tykalova T; Novotny M; Dusek P; Sonka K; Ruzicka E
    IEEE Trans Neural Syst Rehabil Eng; 2018 Aug; 26(8):1495-1507. PubMed ID: 29994713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fluency adaptation in speakers with Parkinson disease: a motor learning perspective.
    Whitfield JA; Delong C; Goberman AM; Blomgren M
    Int J Speech Lang Pathol; 2018 Dec; 20(7):699-707. PubMed ID: 28665156
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of the basal ganglia and cerebellum in adaptation to others' speech rate and rhythm: A study of patients with Parkinson's disease and cerebellar degeneration.
    Späth M; Aichert I; Timmann D; Ceballos-Baumann AO; Wagner-Sonntag E; Ziegler W
    Cortex; 2022 Dec; 157():81-98. PubMed ID: 36274444
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.
    Rusz J; Cmejla R; Růžičková H; Klempíř J; Majerová V; Picmausová J; Roth J; Růžička E
    J Neural Transm (Vienna); 2013 Feb; 120(2):319-29. PubMed ID: 22772465
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Motor asymmetry and hemisphere interactions in Parkinson's disease].
    Sadekov RA; Vendrova MI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):42-6. PubMed ID: 14870692
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The timing of syllable repetitions in developmental dyslexia.
    Wolff PH; Michel GF; Ovrut M
    J Speech Hear Res; 1990 Jun; 33(2):281-9. PubMed ID: 2359268
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Functional data analysis of prosodic prominence in Parkinson's disease: a pilot study.
    Tavi L; Penttilä N
    Clin Linguist Phon; 2024 Mar; 38(1):64-81. PubMed ID: 36636014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Loudness perception and speech intensity control in Parkinson's disease.
    Clark JP; Adams SG; Dykstra AD; Moodie S; Jog M
    J Commun Disord; 2014; 51():1-12. PubMed ID: 25194745
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Longitudinal Effects of Parkinson's Disease on Speech Breathing During an Extemporaneous Connected Speech Task.
    Darling-White M; Anspach Z; Huber JE
    J Speech Lang Hear Res; 2022 Apr; 65(4):1402-1415. PubMed ID: 35302868
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Perceptive and subjective evaluation of speech disorders in Parkinson's disease.
    Melchionda D; Varvara G; Perfetto D; Mascolo B; Avolio C
    J Biol Regul Homeost Agents; 2020; 34(2):683-686. PubMed ID: 32475102
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Speech breathing in Parkinson's disease.
    Solomon NP; Hixon TJ
    J Speech Hear Res; 1993 Apr; 36(2):294-310. PubMed ID: 8487522
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prosodic analysis of neutral, stress-modified and rhymed speech in patients with Parkinson's disease.
    Galaz Z; Mekyska J; Mzourek Z; Smekal Z; Rektorova I; Eliasova I; Kostalova M; Mrackova M; Berankova D
    Comput Methods Programs Biomed; 2016 Apr; 127():301-17. PubMed ID: 26826900
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Speech disorders from Parkinson's disease: try to sing it! A case report.
    Ferriero G; Bettoni E; Picco D; Massazza G; Franchignoni F
    Mov Disord; 2013 May; 28(5):686-7. PubMed ID: 23536464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.